Prometheus Biosciences, Inc., (RXDX) Social Stream



Prometheus Biosciences, Inc., (RXDX): $110.00

1.57 (+1.45%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add RXDX to Watchlist
Sign Up

Industry: Biotech


Ranked

of NR

in industry

PROMETHEUS BIOSCIENCES INC (RXDX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering RXDX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-02 3 $40 $34 $36.333 $114.47 -68.26%
2021-11-15 4 $45 $34 $38.5 $114.47 -66.37%
2021-12-08 5 $50 $40 $44.8 $114.47 -60.86%
2022-01-13 6 $50 $40 $45 $114.47 -60.69%
2022-02-11 7 $62 $40 $47.428 $114.47 -58.57%
2022-03-10 7 $62 $40 $48.571 $114.47 -57.57%
2022-05-12 5 $62 $42 $50 $114.47 -56.32%
2022-05-17 8 $62 $42 $50 $114.47 -56.32%
2022-06-10 8 $62 $42 $50.375 $114.47 -55.99%
2022-07-26 9 $62 $42 $50.444 $114.47 -55.93%
2022-08-11 9 $62 $42 $50.888 $114.47 -55.54%
2022-08-12 9 $62 $42 $53.777 $114.47 -53.02%
2022-08-29 9 $71 $50 $58.555 $114.47 -48.85%
2022-10-03 9 $74 $50 $59.888 $114.47 -47.68%
2022-10-20 9 $74 $50 $62.111 $114.47 -45.74%
2022-11-01 9 $74 $51 $62.666 $114.47 -45.26%
2022-11-10 9 $74 $51 $62.555 $114.47 -45.35%
2022-12-08 9 $185 $51 $117.1 $114.47 2.3%
2022-12-11 9 $185 $51 $127.1 $114.47 11.03%
2022-12-16 9 $185 $51 $137.1 $114.47 19.77%

The Trend in the Analyst Price Target


RXDX's average price target has moved up $92.1 over the prior 48 weeks.

Over the past 44 weeks, RXDX's average upside potential has been 32.92%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-03-10 7 62 40 48.571 50.00 -2.86%
2022-03-10 5 62 42 50.000 50.00 0%
2022-05-12 7 62 42 50.000 23.57 112.13%
2022-10-20 9 74 50 62.111 48.72 27.49%
2022-12-08 9 185 51 117.100 117.21 -0.09%

RXDX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.11 8 1 0 0 0 9

The Trend in the Broker Recommendations


RXDX's average broker recommendation rating improved by 0.03 over the prior 48 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, PROMETHEUS BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is higher than 93.69% of them.
  • In terms of how PROMETHEUS BIOSCIENCES INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -627.86% of that group.
  • In the context of Pharmaceutical Products stocks, PROMETHEUS BIOSCIENCES INC's average analyst price target is higher than 1909.72% of them.
  • RXDX has a greater number of analysts covering the stock than 1279.62% of stocks in the mid market cap category.

Stocks similar to PROMETHEUS BIOSCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are EQRX, VALN, and OGN.

Make investment decisions regarding RXDX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 2.2337 seconds.